nodes	percent_of_prediction	percent_of_DWPC	metapath
Meclizine—Ifenprodil—GRIN1—bipolar disorder	0.0851	0.183	CrCbGaD
Meclizine—Ifenprodil—GRIN2B—bipolar disorder	0.0523	0.112	CrCbGaD
Meclizine—Imatinib—NTRK1—bipolar disorder	0.0512	0.11	CrCbGaD
Meclizine—Loperamide—POMC—bipolar disorder	0.044	0.0945	CrCbGaD
Meclizine—HRH1—Monoamine GPCRs—DRD5—bipolar disorder	0.0273	0.0511	CbGpPWpGaD
Meclizine—Diphenylpyraline—SLC6A3—bipolar disorder	0.0261	0.0561	CrCbGaD
Meclizine—Cinnarizine—CACNA1C—bipolar disorder	0.0242	0.0521	CrCbGaD
Meclizine—HRH1—Amine ligand-binding receptors—DRD5—bipolar disorder	0.023	0.043	CbGpPWpGaD
Meclizine—Fluspirilene—HTR1A—bipolar disorder	0.0196	0.0421	CrCbGaD
Meclizine—Fluspirilene—SLC6A4—bipolar disorder	0.0167	0.036	CrCbGaD
Meclizine—Fluspirilene—DRD2—bipolar disorder	0.0166	0.0358	CrCbGaD
Meclizine—Nefazodone—SLC6A3—bipolar disorder	0.0166	0.0357	CrCbGaD
Meclizine—HRH1—Monoamine GPCRs—HTR1A—bipolar disorder	0.0159	0.0298	CbGpPWpGaD
Meclizine—HRH1—Monoamine GPCRs—HTR2C—bipolar disorder	0.0154	0.0288	CbGpPWpGaD
Meclizine—HRH1—Monoamine GPCRs—DRD1—bipolar disorder	0.0154	0.0288	CbGpPWpGaD
Meclizine—CYP1A2—Methylation—COMT—bipolar disorder	0.0153	0.0285	CbGpPWpGaD
Meclizine—Nefazodone—HTR2C—bipolar disorder	0.015	0.0323	CrCbGaD
Meclizine—HRH1—Monoamine GPCRs—DRD3—bipolar disorder	0.0149	0.0279	CbGpPWpGaD
Meclizine—Prochlorperazine—DRD3—bipolar disorder	0.0148	0.0318	CrCbGaD
Meclizine—Nefazodone—HTR1A—bipolar disorder	0.0146	0.0313	CrCbGaD
Meclizine—HRH1—Monoamine GPCRs—DRD4—bipolar disorder	0.0145	0.0271	CbGpPWpGaD
Meclizine—HRH1—Monoamine GPCRs—DRD2—bipolar disorder	0.0135	0.0252	CbGpPWpGaD
Meclizine—HRH1—Amine ligand-binding receptors—HTR1A—bipolar disorder	0.0134	0.0251	CbGpPWpGaD
Meclizine—HRH1—GPCRs, Class A Rhodopsin-like—GPR50—bipolar disorder	0.0132	0.0248	CbGpPWpGaD
Meclizine—HRH1—Amine ligand-binding receptors—DRD1—bipolar disorder	0.0129	0.0242	CbGpPWpGaD
Meclizine—HRH1—Amine ligand-binding receptors—HTR2C—bipolar disorder	0.0129	0.0242	CbGpPWpGaD
Meclizine—Fluspirilene—HTR2A—bipolar disorder	0.0129	0.0276	CrCbGaD
Meclizine—HRH1—Amine ligand-binding receptors—DRD3—bipolar disorder	0.0125	0.0234	CbGpPWpGaD
Meclizine—Nefazodone—SLC6A4—bipolar disorder	0.0124	0.0267	CrCbGaD
Meclizine—Prochlorperazine—HTR2C—bipolar disorder	0.0124	0.0267	CrCbGaD
Meclizine—HRH1—Amine ligand-binding receptors—DRD4—bipolar disorder	0.0122	0.0228	CbGpPWpGaD
Meclizine—HRH1—Amine ligand-binding receptors—DRD2—bipolar disorder	0.0113	0.0212	CbGpPWpGaD
Meclizine—CYP1A2—Melatonin metabolism and effects—CLOCK—bipolar disorder	0.011	0.0206	CbGpPWpGaD
Meclizine—Cinnarizine—DRD2—bipolar disorder	0.0107	0.0229	CrCbGaD
Meclizine—HRH1—IL-4 Signaling Pathway—GATA3—bipolar disorder	0.0104	0.0194	CbGpPWpGaD
Meclizine—Prochlorperazine—DRD2—bipolar disorder	0.0103	0.022	CrCbGaD
Meclizine—Nefazodone—HTR2A—bipolar disorder	0.00956	0.0205	CrCbGaD
Meclizine—CYP1A2—Estrogen metabolism—COMT—bipolar disorder	0.00953	0.0178	CbGpPWpGaD
Meclizine—HRH1—Monoamine GPCRs—HTR2A—bipolar disorder	0.00944	0.0177	CbGpPWpGaD
Meclizine—HRH1—Amine ligand-binding receptors—HTR2A—bipolar disorder	0.00794	0.0148	CbGpPWpGaD
Meclizine—HRH1—G alpha (q) signalling events—DGKH—bipolar disorder	0.00746	0.014	CbGpPWpGaD
Meclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—bipolar disorder	0.00667	0.0125	CbGpPWpGaD
Meclizine—CYP1A2—Melatonin metabolism and effects—MAOA—bipolar disorder	0.00646	0.0121	CbGpPWpGaD
Meclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.00527	0.00986	CbGpPWpGaD
Meclizine—HRH1—G alpha (q) signalling events—TRPC3—bipolar disorder	0.00517	0.00967	CbGpPWpGaD
Meclizine—HRH1—G alpha (q) signalling events—TACR1—bipolar disorder	0.00481	0.00899	CbGpPWpGaD
Meclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC3—bipolar disorder	0.00462	0.00865	CbGpPWpGaD
Meclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.00452	0.00845	CbGpPWpGaD
Meclizine—CYP1A2—Metapathway biotransformation—AKR1C4—bipolar disorder	0.0043	0.00804	CbGpPWpGaD
Meclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TACR1—bipolar disorder	0.0043	0.00804	CbGpPWpGaD
Meclizine—CYP1A2—Melatonin metabolism and effects—GSK3B—bipolar disorder	0.00424	0.00793	CbGpPWpGaD
Meclizine—HRH1—G alpha (q) signalling events—TAC1—bipolar disorder	0.00392	0.00733	CbGpPWpGaD
Meclizine—HRH1—G alpha (q) signalling events—HTR2C—bipolar disorder	0.00384	0.00719	CbGpPWpGaD
Meclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—bipolar disorder	0.0035	0.00655	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—DRD5—bipolar disorder	0.00344	0.00643	CbGpPWpGaD
Meclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—bipolar disorder	0.00344	0.00643	CbGpPWpGaD
Meclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.00318	0.00595	CbGpPWpGaD
Meclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00318	0.00595	CbGpPWpGaD
Meclizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.00307	0.00575	CbGpPWpGaD
Meclizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.00297	0.00556	CbGpPWpGaD
Meclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.00297	0.00556	CbGpPWpGaD
Meclizine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.00293	0.00548	CbGpPWpGaD
Meclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.00288	0.00538	CbGpPWpGaD
Meclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.00279	0.00522	CbGpPWpGaD
Meclizine—CYP1A2—Phase II conjugation—COMT—bipolar disorder	0.00268	0.00501	CbGpPWpGaD
Meclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00263	0.00493	CbGpPWpGaD
Meclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.0026	0.00487	CbGpPWpGaD
Meclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.00259	0.00485	CbGpPWpGaD
Meclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.00254	0.00476	CbGpPWpGaD
Meclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.00254	0.00476	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—ADM—bipolar disorder	0.00249	0.00465	CbGpPWpGaD
Meclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.00246	0.00461	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—TSHB—bipolar disorder	0.00242	0.00453	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—TACR1—bipolar disorder	0.00242	0.00453	CbGpPWpGaD
Meclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00239	0.00447	CbGpPWpGaD
Meclizine—HRH1—G alpha (q) signalling events—HTR2A—bipolar disorder	0.00236	0.00441	CbGpPWpGaD
Meclizine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.00235	0.0044	CbGpPWpGaD
Meclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00223	0.00417	CbGpPWpGaD
Meclizine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—bipolar disorder	0.00216	0.00404	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—DGKH—bipolar disorder	0.00213	0.00398	CbGpPWpGaD
Meclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—bipolar disorder	0.00211	0.00394	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—HTR1A—bipolar disorder	0.00201	0.00375	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—TAC1—bipolar disorder	0.00198	0.0037	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—DRD5—bipolar disorder	0.00194	0.00364	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—HTR2C—bipolar disorder	0.00194	0.00362	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—DRD1—bipolar disorder	0.00194	0.00362	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—DGKH—bipolar disorder	0.00193	0.00361	CbGpPWpGaD
Meclizine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.00191	0.00357	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—RGS4—bipolar disorder	0.00191	0.00357	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—DRD3—bipolar disorder	0.00188	0.00351	CbGpPWpGaD
Meclizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.00182	0.00341	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—DRD4—bipolar disorder	0.00182	0.00341	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—DRD5—bipolar disorder	0.00177	0.0033	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—RGS4—bipolar disorder	0.00173	0.00324	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—DRD2—bipolar disorder	0.0017	0.00317	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	0.00167	0.00313	CbGpPWpGaD
Meclizine—CYP1A2—Biological oxidations—COMT—bipolar disorder	0.00157	0.00293	CbGpPWpGaD
Meclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.00156	0.00292	CbGpPWpGaD
Meclizine—CYP1A2—Biological oxidations—MAOA—bipolar disorder	0.00156	0.00291	CbGpPWpGaD
Meclizine—CYP1A2—Metapathway biotransformation—COMT—bipolar disorder	0.00155	0.00289	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	0.0015	0.00281	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—TRPC3—bipolar disorder	0.00147	0.00276	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—ADM—bipolar disorder	0.00141	0.00263	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—TSHB—bipolar disorder	0.00137	0.00256	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—PDE4B—bipolar disorder	0.00137	0.00256	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—TACR1—bipolar disorder	0.00137	0.00256	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—IMPA2—bipolar disorder	0.00134	0.00251	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—TRPC3—bipolar disorder	0.00134	0.0025	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—ADM—bipolar disorder	0.00128	0.00239	CbGpPWpGaD
Meclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.00125	0.00233	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—TSHB—bipolar disorder	0.00124	0.00233	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—TACR1—bipolar disorder	0.00124	0.00233	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—PDE4B—bipolar disorder	0.00124	0.00233	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—AKR1C4—bipolar disorder	0.00124	0.00232	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—HTR2A—bipolar disorder	0.00119	0.00222	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—DGKH—bipolar disorder	0.00114	0.00213	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—HTR1A—bipolar disorder	0.00113	0.00212	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—TAC1—bipolar disorder	0.00112	0.00209	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—HTR2C—bipolar disorder	0.00109	0.00205	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—DRD1—bipolar disorder	0.00109	0.00205	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—DRD3—bipolar disorder	0.00106	0.00198	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—DRD5—bipolar disorder	0.00104	0.00195	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—HTR1A—bipolar disorder	0.00103	0.00193	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—DRD4—bipolar disorder	0.00103	0.00193	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—RGS4—bipolar disorder	0.00102	0.00191	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.00102	0.00191	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—TAC1—bipolar disorder	0.00101	0.0019	CbGpPWpGaD
Meclizine—CYP1A2—Biological oxidations—POMC—bipolar disorder	0.00101	0.00189	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—HTR2C—bipolar disorder	0.000994	0.00186	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—DRD1—bipolar disorder	0.000994	0.00186	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—ADCY2—bipolar disorder	0.000969	0.00181	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—DRD3—bipolar disorder	0.000963	0.0018	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—DRD2—bipolar disorder	0.000959	0.00179	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—POMC—bipolar disorder	0.000949	0.00178	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—DRD4—bipolar disorder	0.000935	0.00175	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—IMPA1—bipolar disorder	0.000906	0.00169	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.000885	0.00166	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—ADCY2—bipolar disorder	0.00088	0.00165	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—DRD2—bipolar disorder	0.000871	0.00163	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—TRPC3—bipolar disorder	0.00079	0.00148	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—NDUFV2—bipolar disorder	0.00077	0.00144	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—ADM—bipolar disorder	0.000754	0.00141	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—AKR1C4—bipolar disorder	0.000746	0.00139	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—TSHB—bipolar disorder	0.000735	0.00137	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PDE4B—bipolar disorder	0.000735	0.00137	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—TACR1—bipolar disorder	0.000735	0.00137	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—HTR2A—bipolar disorder	0.000672	0.00126	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—NR1D1—bipolar disorder	0.00067	0.00125	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—NCAN—bipolar disorder	0.000641	0.0012	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SLC5A3—bipolar disorder	0.000628	0.00117	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—HTR2A—bipolar disorder	0.00061	0.00114	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—HTR1A—bipolar disorder	0.000608	0.00114	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—TAC1—bipolar disorder	0.000599	0.00112	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—DRD1—bipolar disorder	0.000587	0.0011	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—HTR2C—bipolar disorder	0.000587	0.0011	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—NTRK2—bipolar disorder	0.000571	0.00107	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—DRD3—bipolar disorder	0.000569	0.00106	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—GSK3A—bipolar disorder	0.000566	0.00106	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—DRD4—bipolar disorder	0.000552	0.00103	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—POMC—bipolar disorder	0.000536	0.001	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—ADCY2—bipolar disorder	0.00052	0.000972	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—TCF7L2—bipolar disorder	0.000518	0.000969	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—DRD2—bipolar disorder	0.000514	0.000962	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—POMC—bipolar disorder	0.000487	0.000911	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—NTRK1—bipolar disorder	0.000466	0.000871	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CLOCK—bipolar disorder	0.000454	0.000849	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—S100B—bipolar disorder	0.000453	0.000847	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—TPH2—bipolar disorder	0.000442	0.000827	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—TSHB—bipolar disorder	0.000442	0.000827	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CACNB2—bipolar disorder	0.000442	0.000827	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—DPYD—bipolar disorder	0.000435	0.000814	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CACNA1C—bipolar disorder	0.000404	0.000757	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—NRG1—bipolar disorder	0.0004	0.000748	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PIK3C2A—bipolar disorder	0.000394	0.000737	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000389	0.000728	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—HTR2A—bipolar disorder	0.00036	0.000674	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SNAP25—bipolar disorder	0.000354	0.000661	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ADCY2—bipolar disorder	0.000313	0.000585	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—GSK3B—bipolar disorder	0.00029	0.000543	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—POMC—bipolar disorder	0.000288	0.000538	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—INS—bipolar disorder	0.000286	0.000535	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—COMT—bipolar disorder	0.000268	0.000501	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—MAOA—bipolar disorder	0.000266	0.000498	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—MTHFR—bipolar disorder	0.000217	0.000405	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—POMC—bipolar disorder	0.000173	0.000324	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—INS—bipolar disorder	0.000172	0.000322	CbGpPWpGaD
